scholarly journals Correlations of SELENOF and SELENOP genotypes with serum selenium levels and prostate cancer

The Prostate ◽  
2018 ◽  
Vol 78 (4) ◽  
pp. 279-288 ◽  
Author(s):  
Dede N. Ekoue ◽  
Emmanuel Ansong ◽  
Li Liu ◽  
Virgilia Macias ◽  
Ryan Deaton ◽  
...  
1999 ◽  
pp. 69 ◽  
Author(s):  
James D. Brooks ◽  
E. Jeffrey Metter ◽  
Daniel W. Chan ◽  
Lori J. Sokoll ◽  
Patricia Landis ◽  
...  

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. e16166-e16166
Author(s):  
M. Nozawa ◽  
M. Yoshida ◽  
Y. Saito ◽  
M. Nakagawa ◽  
T. Ozeki ◽  
...  

e16166 Background: Epidemiologic studies suggest that low selenium levels are associated with an increased incidence of prostate cancer, although results are conflicting. We examined the association between serum selenium levels and risk of prostate cancer in men who received a prostate biopsy in our hospital. Methods: Our prospective study included 82 patients who received a prostate biopsy based on elevated PSA levels over 4.0ng/ml. Serum from each patient was sampled to determine the selenium level at the time of biopsy. Of these, 47 patients were diagnosed with prostate cancer (case group) and no malignant lesions in the biopsy specimen were detected in the remains, 35 patients (control group). Results: The mean serum selenium levels in the case and control group were 120.4 (SD, 14.4) ng/mL and 118.5 (SD, 16.1) ng/mL, respectively (p = 0.588). Serum selenium levels at biopsy were not associated with risk of prostate cancer diagnosis. In the case group, the mean serum selenium levels in patients diagnosed with 6 or less in Gleason score and 7 or more were 121.0 (SD, 9.9) ng/mL (n = 14) and 120.1 (SD, 16.1) ng/mL (n = 33), respectively (p = 0.851). Serum selenium levels at biopsy were not associated with Gleason score in the case group. An inverse association between serum selenium and PSA levels at biopsy was observed (p = 0.030). No correlation was observed between serum selenium level and age at biopsy. Conclusions: From this study, serum selenium level cannot predict the result of prostate biopsy. The inverse association between serum selenium and PSA levels may suggest that low selenium levels are associated with an increased incidence of prostate cancer. No significant financial relationships to disclose.


Medicine ◽  
2017 ◽  
Vol 96 (5) ◽  
pp. e5944 ◽  
Author(s):  
Zhigang Cui ◽  
Dezhong Liu ◽  
Chun Liu ◽  
Gang Liu

2010 ◽  
Vol 6 (2) ◽  
pp. 227
Author(s):  
Mutaz Suyagh ◽  
Peter Sedman ◽  
Prashant Jain ◽  
El-Naseer Salim ◽  
Khaled Hamdan

2010 ◽  
Vol 345 (1-2) ◽  
pp. 23-27 ◽  
Author(s):  
Barbara Kutil ◽  
Petr Ostadal ◽  
Jiri Vejvoda ◽  
Jiri Kukacka ◽  
Jana Cepova ◽  
...  

Biomedicines ◽  
2021 ◽  
Vol 9 (8) ◽  
pp. 991
Author(s):  
Emilia Rogoża-Janiszewska ◽  
Karolina Malińska ◽  
Piotr Baszuk ◽  
Wojciech Marciniak ◽  
Róża Derkacz ◽  
...  

Melanoma is one of the most aggressive human malignancies. The determination of prognostic biomarkers is important for the early detection of recurrence and for the enrollment of the patients into different treatment regimens. Herein, we report the 10-year survival of 375 melanoma patients depending on their serum selenium levels. The study group was followed up from the date of melanoma diagnosis until death or 2020. Patients were assigned to one of four categories, in accordance with the increasing selenium level (I–IV quartiles). The subgroup with low selenium levels had a significant lower survival rate in relation to patients with high selenium levels, HR = 8.42; p = 0.005 and HR = 5.83; p = 0.02, for uni- and multivariable models, respectively. In the univariable analysis, we also confirmed the association between Breslow thickness, Clark classification and age at melanoma prognosis. In conclusion, a low serum selenium level was associated with an increased mortality rate in the 10 years following melanoma diagnosis. Future studies in other geographic regions with low soil selenium levels should be conducted to confirm our findings.


1982 ◽  
Vol 15 (6) ◽  
pp. 281-283 ◽  
Author(s):  
Jan Aaseth ◽  
Jan Alexander ◽  
Yngvar Thomassen ◽  
Jan P. Blomhoff ◽  
Sverre Skrede

Nutrients ◽  
2019 ◽  
Vol 11 (8) ◽  
pp. 1844 ◽  
Author(s):  
Soon Bo Choi ◽  
Yun Tae Jung ◽  
Jae Gil Lee

Low serum selenium levels are commonly observed in critically injured multiple trauma patients. This study aimed to identify the association between initial serum selenium levels and in-hospital infectious complications in multiple trauma patients. We retrospectively reviewed multiple trauma patients admitted between January 2015 and November 2017. We selected 135 patients whose serum selenium levels were checked within 48 h of admission. Selenium deficiency was defined as a serum selenium level <70 ng/mL. Survival analyses of selenium deficiency and 30-day mortality were performed. Multivariate logistic regression analysis was performed to identify the association between initial serum selenium level and in-hospital infectious complications. Thirty-day mortality (8.3% vs. 0.0%; p = 0.018) and incidence rates of pneumonia (66.7% vs. 28.3%; p < 0.001) and infectious complications (83.3% vs. 46.5%; p < 0.001) were higher in patients with selenium deficiency than in patients without selenium deficiency. Kaplan–Meier survival cures also showed similar results (log rank test, p = 0.021). Of 135 patients, 76 (56.3%) experienced at least one infectious complication during admission. High injury severity score (ISS, odds ratio (OR) 1.065, 95% confidence interval (CI) 1.024–1.108; p = 0.002) and selenium deficiency (OR 3.995, 95% CI 1.430–11.156; p = 0.008) increased the risk of in-hospital infectious complications in multiple trauma patients. Patients with selenium deficiency showed higher 30-day mortality and higher risks of pneumonia and infectious complications.


PLoS ONE ◽  
2020 ◽  
Vol 15 (8) ◽  
pp. e0238263
Author(s):  
Stephen Chijioke Eze ◽  
Nathan Azubuike Ododo ◽  
Emmanuel Onyebuchi Ugwu ◽  
Joseph Tochukwu Enebe ◽  
Onyema Athanatius Onyegbule ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document